Editorial
doi: 10.1007/BF01686459.
The role of platinum dose intensity in the management of ovarian cancer
- PMID: 8325902
- PMCID: PMC12200444
- DOI: 10.1007/BF01686459
Item in Clipboard
Editorial
The role of platinum dose intensity in the management of ovarian cancer
J Cancer Res Clin Oncol.
1993.
No abstract available
Similar articles
-
Systematic review of first-line chemotherapy for newly diagnosed postoperative patients with stage II, III, or IV epithelial ovarian cancer.Gynecol Oncol. 2002 Apr;85(1):71-80. doi: 10.1006/gyno.2001.6552. Gynecol Oncol. 2002. PMID: 11925123
-
Different infusion durations for preventing platinum-induced hearing loss in children with cancer.Cochrane Database Syst Rev. 2016 Aug 8;(8):CD010885. doi: 10.1002/14651858.CD010885.pub3. Cochrane Database Syst Rev. 2016. Update in: Cochrane Database Syst Rev. 2018 Jul 05;7:CD010885. doi: 10.1002/14651858.CD010885.pub4. PMID: 27498707 Updated.
-
A systematic overview of chemotherapy effects in ovarian cancer.Acta Oncol. 2001;40(2-3):340-60. doi: 10.1080/02841860151116420. Acta Oncol. 2001. PMID: 11441940
-
Different infusion durations for preventing platinum-induced hearing loss in children with cancer.Cochrane Database Syst Rev. 2018 Jul 5;7(7):CD010885. doi: 10.1002/14651858.CD010885.pub4. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2020 Jan 21;1:CD010885. doi: 10.1002/14651858.CD010885.pub5. PMID: 29975402 Free PMC article. Updated.
-
Optimal dosing with carboplatin.Semin Oncol. 1989 Apr;16(2 Suppl 5):14-8. Semin Oncol. 1989. PMID: 2655094 Review.
Cited by
-
Relationship between the exposure to cisplatin, DNA-adduct formation in leucocytes and tumour response in patients with solid tumours.Br J Cancer. 1996 Jun;73(12):1569-75. doi: 10.1038/bjc.1996.296. Br J Cancer. 1996. PMID: 8664132 Free PMC article.
References
-
- Andrews PA, Velury S, Mann SC, Howell SB (1988)cis-Diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells. Cancer Res 48:68–73 - PubMed
-
- Gershenson DM, Mitchell MF, Atkinson N, Silva EG, Kavanagh JJ, Morris M, Burke TW, Warner D, Wharton JT (1992) The effect of prolonged cisplatin-based chemotherapy on progression-free survival in patients with optimal epithelial ovarian cancer: “Maintenance” therapy reconsidered. Gynecol Oncol 47:7–13 - PubMed
-
- Jodrell DI, Egorin MJ, Canetta RM, Longenberg P, Goldbloom EP, Burroughs JN, Goodlow JL, Tan S, Wiltshaw E (1992) Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer. J Clin Oncol 10:520–528 - PubMed
-
- Kaye SB, Lewis CR, Paul J, Duncan ID, Gordon HK, Kitchener HC, Cruickshank DJ, Atkinson RJ, Soukop M, Rankin EM, Cassidy J, Davis JA, Reed NS, Crawford SM, MacLean A, Swapp GA, Sarkar TK, Kennedy JH, Symonds RP (1992) Randomized study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancer. Lancet 340:329–333 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical